Drug sales confirm clinical advantage of multi-target inhibition of drug escapes by anticancer kinase inhibitors
{{output}}
The clinical advantage of co-targeting cancer drug escape has been indicated by the percentage of these co-targeting drugs among all multi-target drugs in clinics and clinical trials. This clinical advantage needs to be further interrogated from such perspecti... ...
